Flow cytometry follow-up analysis of peripheral blood leukocyte subpopulations in calves experimentally infected with field isolates of Mycoplasma bovis by Dudek, Katarzyna et al.
Acta Veterinaria Hungarica 63 (2), pp. 167–178 (2015) 
DOI: 10.1556/AVet.2015.014 
 
0236-6290/$ 20.00 © 2015 Akadémiai Kiadó, Budapest 
FLOW CYTOMETRY FOLLOW-UP ANALYSIS  
OF PERIPHERAL BLOOD LEUKOCYTE SUBPOPULATIONS  
IN CALVES EXPERIMENTALLY INFECTED  
WITH FIELD ISOLATES OF MYCOPLASMA BOVIS 
Katarzyna DUDEK1*, Dariusz BEDNAREK1, Ewelina SZACAWA1, Ruben S. ROSALES2  
and Roger D. AYLING2 
1Department of Cattle and Sheep Diseases, National Veterinary Research Institute,  
57 Partyzantow Avenue, 24-100 Pulawy, Poland; 2Mycoplasma Team, Animal and Plant 
Health Agency (Weybridge), Woodham Lane, Addlestone, Surrey, KT15 3NB,  
United Kingdom 
(Received 20 October 2014; accepted 17 February 2015) 
Changes in peripheral blood leukocyte subpopulations were investigated in 
calves challenged intratracheally with three different Mycoplasma bovis isolates in 
Groups E1, E2, and E3. The controls received a placebo. Blood samples were col-
lected before challenge and then at days 1 to 7, 14, 21 and 28. White blood cells 
(WBC), polymorphonuclear leukocytes (PMNLs), lymphocytes (LYMs), monocytes, 
eosinophils and basophils (mid-size cells, MID), as well as CD2+, CD4+, CD8+, 
WC4+ lymphocyte subsets with CD4:CD8 ratio were also analysed. A transient 
increase of WBC and PMNLs in all challenged calves was observed on day 1. In-
creased LYM counts were observed in E1 throughout the study, whereas in E2 the 
LYM counts were higher only between days 14 and 28, and consistently lower in 
E3. The MID count had broadly comparable values for all groups. Stimulation of 
the CD2+ response was observed in E2 and E3 in contrast with E1 which had a 
lower CD2+ throughout. The CD4+ response was dominant in E1 and E2, whereas 
in E3 a parallel CD4+ and CD8+ stimulation was observed. The B-cell response 
(WC4+) and an increased CD4:CD8 ratio was most apparent in E1. The main host 
responses to M. bovis infections are a stimulation of CD4+ cells and an enhance-
ment of the WC4+ response. 
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The disease caused by Mycoplasma bovis in cattle is responsible for sub-
stantial economic losses to the farming industry around the world. Infection by 
M. bovis can cause bronchopneumonia, mastitis, arthritis, keratoconjunctivitis, 
otitis, meningitis, and reproductive disorders (Nicholas and Ayling, 2003). In Po-
land, 64.3 per cent of calves affected with bovine respiratory disease (BRD) were 
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found to be seropositive for M. bovis (Dudek and Bednarek, 2012). In other 
European countries the seropositivity rate ranged from 11 to 88 per cent (Le 
Grand et al., 2002; Ayling et al., 2004; Tenk et al., 2004; Radaelli et al., 2008; 
Pardon et al., 2011). 
It has been reported that M. bovis can have both a stimulating and a sup-
pressing effect on host immunity (Dudek et al., 2013). It stimulates activation of 
the acute phase response (APR) in infected calves as a consequence of a signifi-
cant increase in the specific acute phase proteins (APPs) (Dudek et al., 2010, 
2011a, 2013), proinflammatory cytokine production (Jungi et al., 1996), and ac-
tivates the arachidonic acid cascade (Dudek et al., 2011b). In contrast, it has a 
modulating effect on different immune leukocyte functions including the produc-
tion of reactive oxygen species (ROS), but this may vary with each mycoplasma 
isolate. The suppressive effects of M. bovis include impairment of ROS produc-
tion by leukocytes, but without suppression of the general cellular metabolism of 
these cells (Wiggins et al., 2011), and an apoptotic effect on bovine lymphocytes 
has also been reported by Vanden Bush and Rosenbusch (2002). 
This study evaluated changes in peripheral blood leukocyte subpopula-
tions, as detected by flow cytometry, following experimental infection of healthy 
calves with three different M. bovis field isolates. 
 
 
Materials and methods 
The experimental procedures and animal management protocols were un-
dertaken according to the detailed unified requirements of the Polish Local Ethics 
Committee for Animal Experimentation, which also meet the EU requirements. 
Calves 
Twenty-four calves of the Black and White breed, approximately 5 weeks 
old, were obtained from a typical commercial Polish dairy farm. Their suitability 
for use in the study was determined by serological and bacteriological examination 
for BRD pathogens. Three weeks before the experiment nasal swabs were taken 
from each calf, and standard bacterial culture methods were used to detect BRD 
bacterial pathogens including Mycoplasma and Pasteurella species. Serological 
tests for M. bovis used the Bio-X ELISA (Bio-X Diagnostics, Belgium), and tests 
for bovine respiratory syncytial virus (BRSV), parainfluenza-3 virus (PI3V), 
adenovirus type 3, bovine herpesvirus type 1 (BHV-1) and bovine viral diarrhoea 
virus (BVDV) were performed by the use of commercial respiratory ELISA kits 
(Bio-X Diagnostics, Belgium). The calves were randomly divided into four equal 
groups of six animals each: three experimental groups (E1, E2, E3) and a control 
group (C). Each group of calves was housed in individual pens and fed milk re-
placer, hay and water ad libitum. No antibiotic treatment was given. 
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Isolates 
The identification and purity of M. bovis isolates (1, 2 and 3) used in this 
study were confirmed by PCR/DGGE using universal primers (McAuliffe et al., 
2005). Isolate 1 was obtained from milk from a case of clinical mastitis in Po-
land. Isolate 2 was derived from the lungs of a 5-month-old pneumonic calf, and 
isolate 3 was obtained from bovine fetal stomach contents, both originating from 
England. Multilocus sequence typing (MLST) was also performed on these iso-
lates using the method described by Rosales et al. (2015). 
Inoculum preparation 
Each M. bovis isolate was cultured in a total volume of 23 mL of Eaton’s 
medium with gentle shaking (Nicholas and Baker, 1998) at 37 °C with 5% CO2 
for a total of five days. The cultures were centrifuged at 10,000 g for 40 min and 
then resuspended in sterile phosphate-buffered saline (PBS; pH 7.4 ± 0.2), in a 
volume of 23 mL. The final concentrations of the M. bovis inocula were 1.98 × 
107, 1.65 × 107 and 1.58 × 107 CFU/mL for isolates 1, 2 and 3, respectively. Each 
M. bovis inoculum used for the calf challenge was free from any toxin contami-
nation. 
Inoculation 
The experimental calves were intratracheally challenged once with 23 mL 
of the inoculum. Isolate 1 was given to Group E1, isolate 2 to Group E2, and iso-
late 3 to Group E3. The control animals (Group C) received 23 mL of sterile PBS 
administered by the same route. 
Blood samples for laboratory analysis were collected from the calves be-
fore inoculation (day 0), and then at daily intervals up to day 7, and subsequently 
on days 14, 21 and 28. The blood samples were collected from the vena jugularis 
externa of calves into a 1-ml vacutainer with EDTA-K2 anticoagulant. 
Leukogram 
White blood cell (WBC) counts with leukocyte differentiation which in-
cluded neutrophils (polymorphonuclear leukocyte count, PMNL), lymphocytes 
(total lymphocyte count, LYM) and total number of monocytes, eosinophils and 
basophils presenting as mid-size leukocyte count (MID) were determined using 
an automatic blood analyser (Auto Counter AC 920, Swelab Instrument). 
Immunophenotyping of peripheral blood lymphocytes 
Peripheral blood lymphocyte immunophenotyping was performed using a 
flow cytometer (Coulter Epics XL 4C, Beckman Coulter Company, USA) ac-
cording to the Beckman Coulter Operator’s Guide Procedure. T-cell (CD2+), T-
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helper (CD4+), T-cytotoxic suppressor (CD8+) and B-cell (WC4+) antigens were 
determined using the monoclonal antibodies (mAbs) detailed in Table 1. To 
standardise this analysis, anti-CD45 and anti-CD14 mAbs were used. OptiLyse C 
standard procedures for the expression of CD markers were used for the analyses 
of whole blood. Briefly, the first step was an incubation of 50 µl of sample with 
the appropriate mAb for 15 min, followed by the addition of 250 μl of lysing so-
lution (OptiLyse C Lysing Solution, Beckman Coulter) and incubated again for 
15 min. The mixture was then washed once using PBS with 5% inactivated fetal 
calf serum (FCS) and finally resuspended in 0.5 ml of the same PBS with serum. 
For the analysis of WC4+ expression the procedure was modified by using a sec-
ondary mAb, with a longer incubation time of (55 min) and additional cell wash-
ing, six times using PBS enriched with FCS. All steps during the sample incuba-
tion with different kinds of mAbs were performed strictly at room temperature 
(18–25 °C). A flow cytometer and a logarithmic amplifier were used to analyse 
the suspension of cells. The data were acquired as listmodes and analysed in a 
form of histograms using SYSTEM II 3.0 software. The Multigraph programme 
was used to provide additional calculation information and to display the data.  
Table 1 
Panel of monoclonal antibodies (mAbs) used in lymphocyte phenotyping 
Monoclonal antibody* Host origin Format Clone  Type Isotype Kind 
Anti-bovine CD45 mouse FITC CC1 monoclonal IgG1 primary 
Cross-reacting  
anti-human CD14 
 
mouse 
 
RPE-Cy5
 
61D3 
 
monoclonal 
 
IgG1 
 
primary 
Anti-bovine CD2 mouse FITC CC42 monoclonal IgG1 primary 
Anti-bovine CD4 mouse FITC CC8 monoclonal IgG2a primary 
Anti-bovine CD8 mouse FITC CC63 monoclonal IgG2a primary 
Anti-bovine WC4 mouse S/N CC55 monoclonal IgG1 primary 
F(ab')2 anti-mouse 
IgG  rabbit FITC – polyclonal 
 
polyclonal 
IgG 
secondary 
*manufactured by AbD Serotec, a Bio-Rad Company 
 
Statistics 
The significant differences between the mean values recorded in the ex-
perimental and control groups were analysed using one-way analysis of variance 
(ANOVA) followed by Tukey’s RIR post-hoc test, with a statistically significant 
level of P < 0.05 (STATISTICA 10.0 Software, StatSoft Poland). 
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Results 
Status of calves 
No bacterial bovine respiratory disease pathogens were detected by bacte-
rial culture. All calves lacked specific antibodies to M. bovis. In some of the 
animals antibodies developed to BRSV and PI3 viruses, but there was no evi-
dence of seroconversion. 
The effectiveness of calf inoculation using these M. bovis field isolates 
with clinical and microbiological examinations was described by Dudek et al. 
(2013). During the experimental study no clinical changes such as elevated rectal 
temperature (fever) and respiratory changes were reported in the control group. 
However, in all experimental calves the rectal temperature increased to an aver-
age value of 40.5 °C during the first week of the study. Mild respiratory signs of 
sero-mucosal and mucosal nasal discharge with sporadic coughing were ob-
served in all experimental groups. No other adverse clinical signs were observed 
and the calves were not euthanised. 
MLST analysis 
MLST analysis showed that isolate 1 was MLST sequence type 36 (ST36) 
that did not cluster with any of the clonal complexes previously observed 
(Rosales et al., 2015). Isolates 2 and 3 produced two different STs, ST30 and 
ST32, respectively, which clustered in the same clonal complex 1. 
WBC, GRA, LYM and MID counts 
The WBC count was higher in all of the experimental groups than in the 
control group on day 1, but it returned to near the initial level on day 2 (Fig. 1). 
Group E1 had a higher WBC count than the control group throughout the study. 
In Fig. 1 it can be seen that the WBC counts for Groups E2 and E3 between days 
3 and 7 were visibly lower than the values obtained for the control group and 
Group E1. From day 14 the WBC count increased again. A similar trend was ob-
served for the PMNL count (Fig. 2) and the LYM count (Fig. 3). The MID count 
had comparable values for all groups throughout the experiment (Fig. 4). 
CD2+, CD4+, CD8+ and WC4+ percentages and CD4:CD8 positive ratio 
In Group E1, the CD2+ percentage (Fig. 5) was generally decreased 
throughout the study when compared to the control and the other experimental 
groups. In contrast, this percentage was higher, with significant differences at 
day 5, in Groups E2 and E3 than in the control group between days 3 and 5, and 
it increased again in Group E3 on days 14 and 28 (Fig. 5). 
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Between days 2 and 4, markedly increased values of CD4+ percentage 
were noted in the experimental groups as compared to the control group. After 
that the E1 values were comparable to the control (Fig. 6). E2 and E3 had higher 
values for days 5 to 14 with a significant difference between E3 and the control 
at day 6. 
 
Fig. 1. White blood cell (WBC) counts of calves inoculated with three different field isolates of 
Mycoplasma bovis; E1: the group inoculated with isolate 1; E2: the group inoculated with isolate 2; 
E3: the group inoculated with isolate 3; C: control group 
 
Fig. 2. Polymorphonuclear leukocyte (PMNL) count of calves inoculated with three different field 
isolates of Mycoplasma bovis (for group designations see legend to Fig. 1). a: significant differ-
ences at P < 0.05 between Group E2 and the control group; b: significant differences at P < 0.05 
between Group E3 and the control group; d: significant differences at P < 0.05 between Groups E1 
and E3 
 
Fig. 3. Lymphocyte (LYM) count of calves inoculated with three different field isolates of M. bovis 
No. of days after inoculation 
 0 1 2 3 4 5 6 7 14 21 28 
14 
12 
10 
8 
6 
4 
2 
W
BC
 
(1
09
 c
el
ls
/L
) 
No. of days after inoculation 
 0 1 2 3 4 5 6 7 14 21 28 
8 
6 
4 
2 
0 
P
M
N
L 
(1
09
 c
el
ls
/L
) 
No. of days after inoculation 
 0 1 2 3 4 5 6 7 14 21 28 
10 
8 
6 
4 
2 
0 
LY
M
 
(1
09
 c
el
ls
/L
) 
 LEUKOCYTE SUBPOPULATIONS IN CALVES INFECTED WITH MYCOPLASMA BOVIS 173 
Acta Veterinaria Hungarica 63, 2015 
 
Fig. 4. Monocytes, eosinophil and basophil (MID) count of calves inoculated with three different 
field isolates of Mycoplasma bovis 
 
Fig. 5. CD2+ percentage of calves inoculated with three different field isolates of Mycoplasma bo-
vis. a: significant differences at P < 0.05 between Group E2 and the control group; b: significant 
differences at P < 0.05 between Group E3 and the control group; c: significant differences at P < 
0.05 between Group E1 and the control group; d: significant differences at P < 0.05 between 
Groups E1 and E3; e: significant differences at P < 0.05 between Groups E1 and E2 
 
Fig. 6. CD4+ percentage of calves inoculated with three different field isolates of Mycoplasma bo-
vis. b: significant differences at P < 0.05 between Group E3 and the control group 
 
Group E1 had decreased values in CD8+ percentage when compared with 
the other groups of animals for most of the experiment (Fig. 7). A slightly in-
creased response regarding CD8+ percentage was reported in Groups E2 and E3 
until day 6, with a significant increase in the control group and Group E3 at day 14.  
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In the control group the WC4+ percentage (Fig. 8) fluctuated with the low-
est value occurring on day 4 and the highest on day 7. Group E1 had low values 
on days 2 and 7 with significant differences between this group and the control 
group. Group E3 appeared to have a more stable WC4+ response throughout the 
study, while in Group E2 the WC4+ percentage increased between days 6 and 14, 
with a marked rise on day 28 which gave a significant difference in comparison 
with Group E3.  
 
Fig. 7. CD8+ percentage of calves inoculated with three different field isolates of Mycoplasma bo-
vis. a: significant differences at P < 0.05 between Group E2 and the control group; c: significant 
differences at P < 0.05 between Group E1 and the control group 
 
Fig. 8. WC4+ percentage of calves inoculated with three different field isolates of Mycoplasma bo-
vis. a: significant differences at P < 0.05 between Group E2 and the control group; b: significant 
differences at P < 0.05 between Group E3 and the control group; c: significant differences at P < 
0.05 between Group E1 and the control groups; f: significant differences at P < 0.05 between 
Groups E2 and E3 
The CD4:CD8 positive ratio was generally higher in Groups E1 and E2 
(Fig. 9) than in the control group from day 2 until the end of the study, with the 
exception of days 5 and 6 for Group E1 and days 4 and 28 for Group E2. In 
Group E3 this ratio was visibly higher than in the control group on days 2, 5, 6 
and 7. At the remaining days of the study the values for this group were compa-
rable or slightly lower than those in the control group (Fig. 9). 
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Fig. 9. CD4:CD8 positive T cell ratio of calves inoculated with three different field isolates of My-
coplasma bovis 
 
 
Discussion 
Previously Dudek et al. (2013) used a similar experimental design which 
demonstrated the immunomodulatory effect of M. bovis in calves. In response to 
that M. bovis infection both a stimulation and a suppression of immunity in the 
affected calves was observed, depending on the mycoplasma isolate used. In this 
study, a considerable increase in the WBC count in all of the challenged groups 
of calves was observed on day 1 which probably resulted from a stimulation of 
neutrophil production and recirculation. The subsequent decrease to day 7 of 
these cells in Groups E2 and E3 may be due to neutrophil influx into the target 
tissues (Salmon and Higgs, 1987), resulting from a stimulating effect exerted on 
these cells by a powerful chemoattractant, leukotriene B4 (LTB4). The stimulat-
ing effect of LTB4 has already been reported and its mechanism confirmed; how-
ever, previously it was shown that the LTB4 status is decreased in seropositive 
cattle (Dudek et al., 2011b). LTB4 also has a strong chemotactic activity toward 
eosinophils (Traczyk and Trzebski, 2001). 
In Group E1, challenged with an isolate from mastitis, both the WBC and 
PMNL counts were consistently higher than in the controls for most of the study. 
It is therefore possible that this isolate could effectively stimulate neutrophil re-
circulation from the bone marrow to the blood vessels. The inverse effect seen in 
Groups E2 and E3 could be due to the different site of origin of the other M. bo-
vis isolates used for challenge. The similar action of these two isolates on the 
neutrophils may be explained by their close relatedness, being in the same clonal 
complex as shown by MLST typing (Rosales et al., 2015). 
An in vitro study demonstrated that the recall response to M. bovis was re-
lated to both CD4+ and CD8+ expression (Vanden Bush and Rosenbusch, 2003). 
In this study a distinct increase of the CD4+ cells was observed in all experimen-
tal groups, but it was more marked in the group inoculated with the isolate from 
bovine fetal stomach contents. This stimulation could be related to an induction 
of mechanisms responsible for mycoplasma elimination, such as macrophage ac-
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tivation and some co-operative cytokine release. A prominent role of CD4+ re-
sponse in infections caused by M. bovis and other Mycoplasma species such as 
M. agalactiae in goats (Rodríguez et al., 2000) and M. pulmonis in mice (Jones 
et al., 2002) was already discussed. The most evident depletion of CD8+ cells 
was observed for the mastitic isolate which may be linked to the target tissues 
and their local cytotoxic activity. In contrast, a slight stimulation of the CD8+ re-
sponse was shown in the other experimental groups, which may suggest a greater 
recruitment of these cells in the bone marrow and thymus, resulting in an in-
crease in the peripheral T-cytotoxic suppressor cells. In Groups E2 and E3, there 
was a lack of a distinct B-cell response, although the response was more marked 
for the E2 calf pneumonia isolate where increases in the WC4+ percentage were 
observed on days 14 and 28. In this study, the course of the B-cell response 
could be associated with the production of specific antibodies to M. bovis which 
were detected in our previous study in the experimental calves from day 21 for 
Group E2 and from day 14 for Group E3 (Dudek et al., 2013). In contrast, the 
WC4+ count increase was generally stimulated in the calves inoculated with the 
E1 mastitic isolate and specific antibodies to M. bovis were detected from day 
21. However, the production of these antibodies was the most delayed and less 
intense in this group than in the other experimental groups (Dudek et al., 2013). 
In this study the CD4:CD8 positive T cell ratio was generally increased in 
the group challenged with the isolate of cow mastitis origin as a result of in-
creased CD4+ cell percentage during the first days of the study and a distinct de-
cline of the CD8+ cells later in the study. An increased CD4:CD8 positive T cell 
ratio was also observed in the group inoculated with the isolate obtained from 
calf pneumonia, probably as a consequence of CD4+ stimulation. This would also 
account for the fact that the CD4:CD8 positive T cell ratio obtained for the E3 
fetal stomach content isolate was visibly higher than that found in the controls on 
days 2, 6 and 7. Previously the importance of this parameter in the evaluation of 
the immune status of calves experimentally infected with Mannheimia haemo-
lytica A1 leukotoxin (Bednarek et al., 2009) or following a commercial vaccina-
tion (Dudek et al., 2009) was demonstrated. Additionally, CD4:CD8 imbalance 
could be a useful indicator of intensified or diminished T-cell immune response, 
and this information may be useful for diagnosis. 
The immune response to M. bovis varies with the isolate used, which may 
be related to the source of the isolate, the molecular type or the surface protein 
profile. Further work should analyse the variable surface proteins expressed by 
these isolates during infection. However, this study has demonstrated that the 
main host responses to M. bovis infections are the stimulation of T-helper cells 
and the enhancement of response regarding B lymphocytes. It is worth noting 
that these responses were evaluated in the peripheral blood of calves but they 
may, at least partially, reflect changes in leukocyte subsets in the secondary lym-
phoid organs as well. 
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